Absorption |
Blood-Brain Barrier | BBB+ | 0.9762 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7733 |
P-glycoprotein Substrate | Substrate | 0.7066 |
P-glycoprotein Inhibitor | Inhibitor | 0.7716 |
Non-inhibitor | 0.7160 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7901 |
Distribution |
Subcellular localization | Mitochondria | 0.8483 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8251 |
CYP450 2D6 Substrate | Non-substrate | 0.9117 |
CYP450 3A4 Substrate | Substrate | 0.7701 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9425 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9506 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6103 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9304 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9526 |
Non-inhibitor | 0.7342 |
AMES Toxicity | Non AMES toxic | 0.9345 |
Carcinogens | Non-carcinogens | 0.9474 |
Fish Toxicity | High FHMT | 0.9924 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9834 |
Honey Bee Toxicity | High HBT | 0.8245 |
Biodegradation | Not ready biodegradable | 0.9754 |
Acute Oral Toxicity | IV | 0.5200 |
Carcinogenicity (Three-class) | Non-required | 0.5040 |